Publications by authors named "Martin J Sims"

Claim this Profile
T
The IAP antagonist tolinapant enhances the anti-tumor activity of cell therapies.
Keisuke Tazuru, Masayuki Sone, Hiroki Akamine, Yosuke Kogue, Martin J Sims

Eur J Pharmacol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The identification of functional regions of MEK1 using CRISPR tiling screens.
Zhiqiang Zhang, Barbara Abreu, Jessica L Brothwood, John Alexander, Martin J Sims

Commun Biol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonism of inhibitors of apoptosis proteins reveals a novel, immune response-based therapeutic approach for T-cell lymphoma.
Nicola Ferrari, George Ward, Christina Gewinner, Matthew P Davis, Simone Jueliger, Martin J Sims

Blood Adv· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic medicine: novel strategies for clinical trials.
Andrea A Itano, Martin J Sims, Gerald Siu

Autoimmunity· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-4-Pyrimidinyl-1H-indazol-4-amine inhibitors of Lck: indazoles as phenol isosteres with improved pharmacokinetics.
Paul Bamborough, Richard M Angell, Inder Bhamra, David Brown, James Bull, Martin J Sims

Bioorg Med Chem Lett· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis